Glucocorticoids are widely used in the therapy of RA patients; they reduce inflammatory cell counts in tissues and decrease levels of inflammatory cytokines such as TNFα, IL-1 β, IL-6, and IL-17 [37]. This evidence concerns the gene IL17A and rheumatoid arthritis.